Regeneron Pharmaceuticals, Inc.
Human Serum Albumin in Formulations
Last updated:
Abstract:
Drug formulations and methods for removing, reducing, or preventing the formation of fatty acid particles in drug formulations are provided.
Status:
Application
Type:
Utility
Filling date:
3 Mar 2020
Issue date:
10 Sep 2020